Severe Bradycardia Leading to Hemodynamic Instability Associated with Remdesivir Use in a Patient with COVID-19 Pneumonia

Remdesivir (RDV) is an approved treatment for hospitalized patients with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. There is limited literature on the cardiac adverse effects of RDV. We report a case of a patient who developed hemodynamically unstable bradycardia after t...

Full description

Saved in:
Bibliographic Details
Main Authors: Bhargavi Donepudi, Shikhar Agarwal, Lokendra Thakur
Format: Article
Language:English
Published: Wiley 2022-01-01
Series:Case Reports in Critical Care
Online Access:http://dx.doi.org/10.1155/2022/8807957
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832562423705370624
author Bhargavi Donepudi
Shikhar Agarwal
Lokendra Thakur
author_facet Bhargavi Donepudi
Shikhar Agarwal
Lokendra Thakur
author_sort Bhargavi Donepudi
collection DOAJ
description Remdesivir (RDV) is an approved treatment for hospitalized patients with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. There is limited literature on the cardiac adverse effects of RDV. We report a case of a patient who developed hemodynamically unstable bradycardia after the initiation of RDV that resolved after discontinuing RDV.
format Article
id doaj-art-ae3c597040a0426ba3290419c074ef5b
institution Kabale University
issn 2090-6439
language English
publishDate 2022-01-01
publisher Wiley
record_format Article
series Case Reports in Critical Care
spelling doaj-art-ae3c597040a0426ba3290419c074ef5b2025-02-03T01:22:40ZengWileyCase Reports in Critical Care2090-64392022-01-01202210.1155/2022/8807957Severe Bradycardia Leading to Hemodynamic Instability Associated with Remdesivir Use in a Patient with COVID-19 PneumoniaBhargavi Donepudi0Shikhar Agarwal1Lokendra Thakur2Department of Critical Care MedicineDepartment of CardiologyDepartment of Critical Care MedicineRemdesivir (RDV) is an approved treatment for hospitalized patients with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. There is limited literature on the cardiac adverse effects of RDV. We report a case of a patient who developed hemodynamically unstable bradycardia after the initiation of RDV that resolved after discontinuing RDV.http://dx.doi.org/10.1155/2022/8807957
spellingShingle Bhargavi Donepudi
Shikhar Agarwal
Lokendra Thakur
Severe Bradycardia Leading to Hemodynamic Instability Associated with Remdesivir Use in a Patient with COVID-19 Pneumonia
Case Reports in Critical Care
title Severe Bradycardia Leading to Hemodynamic Instability Associated with Remdesivir Use in a Patient with COVID-19 Pneumonia
title_full Severe Bradycardia Leading to Hemodynamic Instability Associated with Remdesivir Use in a Patient with COVID-19 Pneumonia
title_fullStr Severe Bradycardia Leading to Hemodynamic Instability Associated with Remdesivir Use in a Patient with COVID-19 Pneumonia
title_full_unstemmed Severe Bradycardia Leading to Hemodynamic Instability Associated with Remdesivir Use in a Patient with COVID-19 Pneumonia
title_short Severe Bradycardia Leading to Hemodynamic Instability Associated with Remdesivir Use in a Patient with COVID-19 Pneumonia
title_sort severe bradycardia leading to hemodynamic instability associated with remdesivir use in a patient with covid 19 pneumonia
url http://dx.doi.org/10.1155/2022/8807957
work_keys_str_mv AT bhargavidonepudi severebradycardialeadingtohemodynamicinstabilityassociatedwithremdesiviruseinapatientwithcovid19pneumonia
AT shikharagarwal severebradycardialeadingtohemodynamicinstabilityassociatedwithremdesiviruseinapatientwithcovid19pneumonia
AT lokendrathakur severebradycardialeadingtohemodynamicinstabilityassociatedwithremdesiviruseinapatientwithcovid19pneumonia